Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 2

NCT07034807 is registered in ClinicalTrials.gov with Liu Hongfang as lead sponsor.

NCT NCT07034807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 2
Lead sponsor
Liu Hongfang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 31, 2028
Enrollment
228 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease (dkd)